Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Non-interventional, Prospective Study to Collect Efficacy and Safety Data in Chinese Patients Who Have Received Faslodex 250mg Treatment Under the Condition of Actual Usage in Clinical Practice

NCT01425294 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01425294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Non-interventional, Prospective Study to Collect Efficacy and Safety Data in Chinese Patients Who Have Received Faslodex 250mg Treatment Under the Condition of Actual Usage in Clinical Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
August 1, 2011
Completion date
January 30, 2016
Enrollment
231 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer